Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Lastly, new holding, Norwegian Cruise Line Holdings Ltd. (NCLH) declined alongside the sector during the period, following investor concerns about a potential new tax on cruise lines. Although, we believe...
— John W. Rogers
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Norwegian Cruise Line Holdings, Ltd.
Norwegian Cruise Line Holdings, Ltd. ($NCLH) accounts for 2.7% of the composite portfolio and operates contemporary and luxury cruise vessels globally under the Norwegian, Oceania, and Regent Seven Seas brands. Despite sharp share...
Norwegian Cruise Line Holdings ($NCLH) is a global leisure cruise operator that was completely divested during the quarter, bringing its position weight down to 0.0%. The manager adopted...
Norwegian Cruise Line Holdings ($NCLH) is a global cruise operator that accounts for 2.5% of fund assets. The manager expresses...
More institutional theses from Ariel Appreciation Fund
OneSpaWorld Holdings ($OSW), holding a 2.6% position in the portfolio, is the dominant global provider of outsourced health, wellness, and spa services onboard luxury cruise vessels and destination resorts. The manager maintains...
Charles River Laboratories ($CRL), which represents 3.9% of the fund's portfolio, is an essential contract research organization providing discovery and safety assessment services, laboratory products, and manufacturing support to the global biopharmaceutical industry. The manager holds...
Haemonetics Corporation ($HAE), constituting 2.7% of the fund, develops and distributes specialized hematology technologies, blood management products, and plasma collection solutions. The manager is...